APYX icon

Apyx Medical
APYX

32 hedge funds and large institutions have $13M invested in Apyx Medical in 2015 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,981% more capital inflows, than outflows

Capital inflows: $14.8M | Capital outflows: $480K

367% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 3

52% more funds holding

Funds holding: 21 → 32 (+11)

20% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 5

17.65% more ownership

Funds ownership: 6.4% → 24.06% (+18%)

Holders
32
Holders Change
+11
Holders Change %
+52.38%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
6
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
+$3.36M
2
DM
Deerfield Management
New York
+$2.33M
3
GMCM
Gruber & McBaine Capital Management
California
+$1.66M
4
KCM
Kennedy Capital Management
Missouri
+$1.66M
5
GPP
Great Point Partners
Connecticut
+$1.6M

Top Sellers

Rank Fund Capital Flow
1
MIAN
Mariner Independent Advisor Network
Kansas
-$223K
2
Millennium Management
Millennium Management
New York
-$91.4K
3
Northern Trust
Northern Trust
Illinois
-$87.7K
4
First Manhattan
First Manhattan
New York
-$51K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$11.1K

APYX Hedge Fund Activity: Q1 2015 in Review

32 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q1 2015, worth a combined $13M — up 213% from $4.17M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new APYX positions and 3 closed out — a net gain of 11 holders — while 6 added to existing stakes and 5 trimmed.

The largest buyer was Broadfin Capital, opening a new position worth an estimated $3.36M. The largest seller was Mariner Independent Advisor Network, exiting entirely with an estimated $223K sold.

  • 32 institutional investors held Apyx Medical (APYX) as of Q1 2015, up from 21 in Q4 2014.
  • Funds reported $13M of Apyx Medical stock for Q1 2015, up 213% quarter-over-quarter.
  • 14 funds opened new Apyx Medical positions in Q1 2015 and 3 closed out, a net change of +11 holders.
  • The largest Apyx Medical buyer in Q1 2015 was Broadfin Capital, an estimated $3.36M added.
  • The largest Apyx Medical seller in Q1 2015 was Mariner Independent Advisor Network, an estimated $223K sold.

Based on aggregated 13F filings for Q1 2015.